# Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma

> **NCT00470275** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 10 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** cytarabine

## Key facts

- **NCT ID:** NCT00470275
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-08
- **Final completion:** 2013-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470275, "Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00470275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*